In 2024, 4% of U.S. adults were prescribed a GLP-1 therapy — a 363.7% increase from 0.9% in 2019, according to a Fair Health analysis of more than 51 billion commercial claim records.  Fair Health ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may cut the risk of obesity-related cancer (ORC) in patients being treated for diabetes and obesity.

Carrying extra pounds on your body can put you at risk of diabetes, high blood pressure, heart disease, and even cancer.

Over two percent of adult patients now take a GLP-1 drug to treat overweight or obesity, according to newly released FAIR ...

Erin Davis/Axios VisualsMore than 2% of Americans are taking the blockbuster class of GLP-1 drugs for overweight or obesity, up nearly 600% over six years, according to a report from FAIR Health given ...

6000-Lb Diaries With Dr. Now aired its premiere episode on Monday, May 26 on Lifetime —and viewers were naturally curious ...

Access remains limited to these effective but expensive drugs, even for patients covered by Medicaid, because of stringent prerequisites that must be satisfied before starting the drug.

Destinee and Dynastiee are identical twins who need to lose weight. Combined they weigh 1,200 pounds and seek help from ...